These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27079968)

  • 1. Two human immunodeficiency virus Type 2 cases in US blood donors including serologic, molecular, and genomic characterization of an epidemiologically unusual case.
    Stramer SL; Yu G; Herron R; Espinoza N; Foster GA; Naccache SN; Brodsky JP; Ong E; Linnen JM; Dyer N; Styer LM; Parker MM; Chiu CY
    Transfusion; 2016 Jun; 56(6 Pt 2):1560-8. PubMed ID: 27079968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
    Fang CT; Field SP; Busch MP; Heyns Adu P
    Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period.
    Ling AE; Robbins KE; Brown TM; Dunmire V; Thoe SY; Wong SY; Leo YS; Teo D; Gallarda J; Phelps B; Chamberland ME; Busch MP; Folks TM; Kalish ML
    JAMA; 2000 Jul; 284(2):210-4. PubMed ID: 10889595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of blood-borne HIV transmission using a decentralized approach in Shaba, Zaire.
    Laleman G; Magazani K; Perriëns JH; Badibanga N; Kapila N; Konde M; Selemani U; Piot P
    AIDS; 1992 Nov; 6(11):1353-8. PubMed ID: 1472338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study.
    Busch MP; Kleinman SH; Williams AE; Smith JW; Ownby HE; Laycock ME; Lee LL; Pau CP; Schreiber GB
    Transfusion; 1996 Jan; 36(1):37-44. PubMed ID: 8607151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1/2 screening in blood centers: implementing a two-step serological screening assay approach to reduce donor deferral.
    Stoyanov E; Gozlan Y; Wax M; Levin E; Shvartz L; Shinar E; Mendelson E; Mor O
    Transfusion; 2019 Jun; 59(6):2054-2060. PubMed ID: 30893485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing a reentry procedure for human immunodeficiency virus screening-reactive donors in China.
    Li L; Xu T; Yang T; Zang L; Cheng W; Lin H; Zhu S; Zhao B; Duan R; Li C; Huang M; Liu Y; Ming C; Xu S; Wang C; Wu Y; Liu Z
    Transfusion; 2016 Jan; 56(1):195-202. PubMed ID: 26360920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of HIV infection from transfusion with blood negative for HIV antibody in a west African city.
    Savarit D; De Cock KM; Schutz R; Konate S; Lackritz E; Bondurand A
    BMJ; 1992 Aug; 305(6852):498-502. PubMed ID: 1327367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group.
    Busch MP; Dodd RY; Lackritz EM; AuBuchon JP; Birkmeyer JD; Petersen LR
    Transfusion; 1997 Oct; 37(10):1003-11. PubMed ID: 9354817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of an HIV-2 antibody-positive blood donor in the United States.
    Sullivan MT; Guido EA; Metler RP; Schable CA; Williams AE; Stramer SL
    Transfusion; 1998 Feb; 38(2):189-93. PubMed ID: 9531953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections.
    Nelson KE; Donahue JG; Muñoz A; Cohen ND; Ness PM; Teague A; Stambolis VA; Yawn DH; Callicott B; McAllister H
    Ann Intern Med; 1992 Oct; 117(7):554-9. PubMed ID: 1524329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine HIV screening among blood donors in Buenos Aires (Argentina): results from six years' experience and report of a single window-period donation.
    Gendler SA; Pascuccio MS
    Enferm Infecc Microbiol Clin; 2007 Feb; 25(2):82-90. PubMed ID: 17288905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-associated human immunodeficiency virus type 1 from screened antibody-negative blood donors.
    Roberts CR; Longfield JN; Platte RC; Zielmanski KP; Wages J; Fowler A
    Arch Pathol Lab Med; 1994 Dec; 118(12):1188-92. PubMed ID: 7979912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
    Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
    Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States.
    Lackritz EM; Satten GA; Aberle-Grasse J; Dodd RY; Raimondi VP; Janssen RS; Lewis WF; Notari EP; Petersen LR
    N Engl J Med; 1995 Dec; 333(26):1721-5. PubMed ID: 7491134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS).
    Glynn SA; Kleinman SH; Schreiber GB; Busch MP; Wright DJ; Smith JW; Nass CC; Williams AE
    JAMA; 2000 Jul; 284(2):229-35. PubMed ID: 10889598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transfusion HIV infection despite donor screening: a report of three cases.
    Martlew VJ; Carey P; Tong CY; Parry JV; Belda FJ; Barlow KL; Chu P; Syed Q
    J Hosp Infect; 2000 Feb; 44(2):93-7. PubMed ID: 10662558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of hepatitis C virus and human immunodeficiency virus false-positive results in serologic screening in sub-Saharan Africa: adverse impact on the blood supply.
    Candotti D; Sauvage V; Cappy P; Boullahi MA; Bizimana P; Mbensa GO; Oumar Coulibaly S; Rakoto Alson AO; Soumana H; Tagny-Tayou C; Murphy EL; Laperche S;
    Transfusion; 2020 Jan; 60(1):106-116. PubMed ID: 31777096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.